University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau—a protein in the brain associated with Alzheimer’s dementia.
Clinical trials are the next step for testing vaccine against Alzheimer’s-promoting tau protein
